Context Therapeutics Inc.(NASDAQ:CNTX) 
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a selective potent antagonist of the progesterone receptor that is linked to resis...
Website: http://www.contexttherapeutics.com
Founded: 2015
CEO: Martin Lehr
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.70
H 0.72
L 0.59
C 0.60
V 478,832
10EMA 0.60
20EMA 0.60
60EMA 0.60
120EMA 0.60
250EMA 0.60